Eli Kaplan is the founder of Novaremed AG. Novaremed AG has raised $66M in total funding. Backed by Global Emerging Markets. Based in Basel, Switzerland.
Eli Kaplan is the Founder and Chief Innovator of Novaremed AG, a clinical-stage Swiss biopharmaceutical company. Novaremed is developing NRD135S.E1, an orally active non-opioid small molecule for treating Painful Diabetic Peripheral Neuropathy (PDPN). The company has raised CHF23.5 million since its inception.
Full founder directory · Investor directory · Company funding database · Fundraising library